SYSTEMATIC REVIEW
Accepted on 29 Sep 2025
Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (OMOC): A Systematic Review and Meta-Analysis of Clinical Outcomes and Toxicity Profiles
doi 10.3389/fphar.2025.1620922
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advances in Ovarian Cancer Therapeutics
Advances in Ovarian Cancer Therapeutics
2,431
Total downloads
12k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 17 Jul 2025
Progress of targeted FOX family therapy in ovarian cancer
doi 10.3389/fphar.2025.1604998
- 868 views
ORIGINAL RESEARCH
Published on 05 Jun 2025
A novel mitochondrial autophagy and aging-related gene signature for predicting ovarian cancer
doi 10.3389/fimmu.2025.1594021
- 2,181 views
ORIGINAL RESEARCH
Published on 04 Jun 2025
Integrated machine learning and single-cell analysis reveal the prognostic and therapeutic potential of SUMOylation-related genes in ovarian cancer
doi 10.3389/fimmu.2025.1577781
- 2,235 views
ORIGINAL RESEARCH
Published on 29 May 2025
The potential of ME1 in guiding immunotherapeutic strategies for ovarian cancer: insights from pan-cancer research
doi 10.3389/fimmu.2025.1571842
- 1,592 views
MINI REVIEW
Published on 24 Apr 2025
Research progress on ferroptosis and PARP inhibitors in ovarian cancer: action mechanisms and resistance mechanisms
doi 10.3389/fphar.2025.1598279
- 2,431 views
- 1 citation
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: